UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 20,
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Genprex Charts.
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Genprex Charts.

Genprex, Inc. News

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences
Wednesday 1 May 2024 (4 days ago) • PR Newswire (US)
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Tuesday 9 April 2024 (4 weeks ago) • PR Newswire (US)
Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
Wednesday 3 April 2024 (1 month ago) • PR Newswire (US)
Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)
Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Saturday 23 March 2024 (1 month ago) • PR Newswire (US)
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Wednesday 20 March 2024 (2 months ago) • PR Newswire (US)
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tuesday 19 March 2024 (2 months ago) • PR Newswire (US)
Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers
Wednesday 13 March 2024 (2 months ago) • PR Newswire (US)
Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Thursday 7 March 2024 (2 months ago) • PR Newswire (US)
Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

More Genprex, Inc. News Articles